SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-22-005734
Filing Date
2022-03-10
Accepted
2022-03-10 16:41:54
Documents
5
Effectiveness Date
2022-03-10

Document Format Files

Seq Description Document Type Size
1 S-8 a032022s-8.htm S-8 77566
2 EX-FILING FEES ex107calculationoffilingfee.htm EX-FILING FEES 25831
3 EX-5.1 ex51legalopinion.htm EX-5.1 13307
4 EX-23.1 a231pricewaterhousecoopers.htm EX-23.1 2646
5 image_0.jpg GRAPHIC 8359
  Complete submission text file 0001628280-22-005734.txt   132096
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263430 | Film No.: 22729634
SIC: 2836 Biological Products, (No Diagnostic Substances)